A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
PHASE1This is an open-label, multicenter, Phase 1/2 study evaluating the safety a...
Location
University of Kansas
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
PHASE1This is a single-arm, open-label, multicenter, ascending dose Phase 1/2 tri...
Location
Mayo Clinic in Rochester
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
PHASE1This is a single-arm, open-label, multicenter, ascending dose Phase 1 study...
Location
UC San Diego Health